LXW7

LXW7, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor. LXW7 has a high binding affinity to αvβ3 integrin with an IC50 of 0.68 μM. LXW7 increases the phosphorylation of VEGFR-2 and activation of ERK1/2.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
LXW7(CAS 1313004-77-1)

CAT No: R1876

CAS No:1313004-77-1

Synonyms/Alias:LXW7;1313004-77-1;SCHEMBL15082201;H-D-Cys(1)-Gly-Arg-Gly-Asp-D-Asp-D-Val-D-Cys(1)-NH2;HY-P0178;CS-0021086;[(4S,7R,10R,13S,19S,25S)-25-amino-19-(3-carbamimidamidopropyl)-4-carbamoyl-10-(carboxymethyl)-7-isopropyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaazacyclohexacosan-13-yl]acetic acid;2,2'-((4S,7R,10R,13S,19S,25S)-25-Amino-4-carbamoyl-19-(3-guanidinopropyl)-7-isopropyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptaazacyclohexacosane-10,13-diyl)diacetic acid;2-[(4S,7R,10R,13S,19S,25S)-25-amino-4-carbamoyl-10-(carboxymethyl)-19-[3-(diaminomethylideneamino)propyl]-6,9,12,15,18,21,24-heptaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacos-13-yl]acetic acid;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C29H48N12O12S2
M.W/Mr.
820.9
Sequence
One Letter Code:CGRGDDVC
Three Letter Code:H-D-Cys(1)-Gly-Arg-Gly-Asp-D-Asp-D-Val-D-Cys(1)-NH2
Purity
>98 %

LXW7 is a synthetic peptide compound designed for high-affinity binding to integrin receptors, particularly those of the αvβ3 subtype. As a cyclic peptide ligand, it has garnered significant attention in the biochemical and biomedical research communities for its specificity and versatility in modulating cell-extracellular matrix interactions. The structural features of LXW7, including its cyclic conformation and tailored amino acid sequence, confer remarkable stability and receptor selectivity, making it a valuable tool for probing integrin-mediated signaling pathways. Its application extends across diverse research fields, from cell adhesion studies to advanced biomaterials development, underscoring its functional significance in elucidating integrin biology and facilitating innovative experimental designs.

Cell Adhesion Research: LXW7 is widely utilized in investigations of cell adhesion mechanisms, particularly those involving endothelial cells and tumor cells expressing high levels of αvβ3 integrin. By serving as a selective ligand, it enables researchers to dissect the molecular basis of integrin-mediated cell attachment, spreading, and migration on various substrates. The peptide's specificity supports detailed studies on the role of integrins in cellular communication with the extracellular matrix, providing insights into fundamental processes such as angiogenesis, wound healing, and cell motility.

Surface Functionalization: In biomaterials science, LXW7 is frequently employed to functionalize surfaces of scaffolds, hydrogels, and implantable devices. Its integrin-targeting capability allows for the creation of bioactive surfaces that promote selective cell adhesion and proliferation. By immobilizing the peptide onto material interfaces, researchers can modulate cellular responses and enhance the biocompatibility of engineered constructs, which is critical for tissue engineering, regenerative medicine, and in vitro model development.

Targeted Cell Capture: The peptide's high affinity for αvβ3 integrin is leveraged in the development of targeted cell capture systems. LXW7 can be conjugated to magnetic beads, microfluidic channels, or other platforms to selectively isolate specific cell populations from complex biological samples. This approach is particularly valuable for enriching endothelial progenitor cells or circulating tumor cells, thereby enabling downstream analyses such as gene expression profiling, phenotypic characterization, or functional assays.

Biosensor Development: LXW7's integrin-binding properties are also exploited in the design of biosensor platforms aimed at detecting cell adhesion events or monitoring integrin expression levels. By incorporating the peptide into sensor surfaces, researchers can achieve sensitive and selective detection of target cells or biomolecular interactions. Such biosensors have applications in basic research, drug screening, and diagnostic assay development, offering a robust means to study integrin dynamics in real time.

Peptide-Protein Interaction Studies: As a well-characterized integrin ligand, LXW7 serves as a model system for studying peptide-protein interactions relevant to cell signaling and receptor-ligand recognition. Its defined sequence and binding profile make it an ideal probe for structure-activity relationship analyses, affinity measurements, and competitive binding assays. These studies contribute to a deeper understanding of integrin-ligand specificity and can inform the rational design of next-generation peptides or small molecules targeting integrin-mediated pathways.

Shipping Condition
Evaluation sample solution: ship with blue ice. All other available sizes: ship with RT, or blue ice upon request.
InChI
InChI=1S/C29H48N12O12S2/c1-12(2)22-28(53)40-17(23(31)48)11-55-54-10-13(30)24(49)35-8-18(42)37-14(4-3-5-34-29(32)33)25(50)36-9-19(43)38-15(6-20(44)45)26(51)39-16(7-21(46)47)27(52)41-22/h12-17,22H,3-11,30H2,1-2H3,(H2,31,48)(H,35,49)(H,36,50)(H,37,42)(H,38,43)(H,39,51)(H,40,53)(H,41,52)(H,44,45)(H,46,47)(H4,32,33,34)/t13-,14+,15+,16-,17-,22-/m1/s1
InChI Key
UUJIUMRQOUEUEJ-NBJCVSNRSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide CDMOPeptide Analysis ServicesPeptide Modification ServicesPeptide Nucleic Acids SynthesiscGMP Peptide ServicePeptide Synthesis ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers